J1307
HCPCSInj, crovalimab-akkz, 10 mg
Official HCPCS Level II long descriptor
Injection, crovalimab-akkz, 10 mg
HCPCS Level II code J1307 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, crovalimab-akkz, 10 mg
Added to HCPCS: 2025-01-01
Nearby codes in J1
- J1290Ecallantide injection
- J1299Inj, eculizumab, 2 mg
- J1301Injection, edaravone, 1 mg
- J1302Inj, sutimlimab-jome, 10 mg
- J1303Inj., ravulizumab-cwvz 10 mg
- J1304Inj tofersen intrathec 1 mg
- J1305Inj, evinacumab-dgnb, 5mg
- J1306Injection, inclisiran, 1 mg
- J1308Inj, famotidine, 0.25 mg
- J1320Amitriptyline injection
- J1322Elosulfase alfa, injection
- J1323Inj, elranatamab-bcmm, 1 mg
- J1324Enfuvirtide injection
- J1325Epoprostenol injection
- J1326Inj, zolbetuximab-clzb, 2 mg
- J1327Eptifibatide injection
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.